(Q57832137)

5

0 references

author name string

Lene S. Knudsen

1

0 references

Ib J. Christensen

2

0 references

Tine Lottenburger

3

0 references

Mads N. Svendsen

4

0 references

Lone Nielsen

6

0 references

Jens E. B. Jensen

8

0 references

Gina Kollerup

9

0 references

Julia S. Johansen

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

10

0 references

publication date

January 2008

0 references

published in

Biomarkers

0 references

volume

13

0 references

issue

1

0 references

page(s)

59-78

0 references

cites work

1 reference

https://api.crossref.org/works/10.1080%2F13547500701615017

Circadian rhythm of serum interleukin-6 in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500701615017

Biomarkers and surrogate endpoints: preferred definitions and conceptual framework

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500701615017

Involvement of IL-6 in the pathogenesis of inflammatory bowel disease and colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500701615017

Effects of treatment with a fully human anti-tumour necrosis factor alpha monoclonal antibody on the local and systemic homeostasis of interleukin 1 and TNFalpha in patients with rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500701615017

Aging, longevity, inflammation, and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500701615017

Cytokine pathways and joint inflammation in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500701615017

Nocturnal hormones and clinical rhythms in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500701615017

The effects of anticoagulation and processing on assays of IL-6, sIL-6R, sIL-2R and soluble transferrin receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500701615017

Soluble tumour necrosis factor receptor treatment does not affect raised transforming growth factor beta levels in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500701615017

Muscle-derived interleukin-6: mechanisms for activation and possible biological roles

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500701615017

Interleukin-6: An osteotropic factor influencing bone formation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500701615017

Synovium as a source of interleukin 6 in vitro. Contribution to local and systemic manifestations of arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500701615017

Biological variations, genetic polymorphisms and familial resemblance of TNF-alpha and IL-6 concentrations: STANISLAS cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500701615017

The association between interleukin-6, sleep, and demographic characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500701615017

IL-6 in autoimmune disease and chronic inflammatory proliferative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500701615017

A single measurement of biochemical markers of bone turnover has limited utility in the individual person.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500701615017

IL-6 signal transduction and its physiological roles: the signal orchestration model

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500701615017

Levels of circulating tumor necrosis factor alpha and interleukin-6 in patients with rheumatoid arthritis. Relationship to serum levels of hyaluronan and antigenic keratan sulfate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500701615017

Cytokine networks--towards new therapies for rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500701615017

A variety of cytokines and immunologically relevant surface molecules are expressed by normal human skeletal muscle cells under proinflammatory stimuli

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500701615017

Anti-interleukin 6 receptor antibody treatment in rheumatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500701615017

Treatment of rheumatoid arthritis with humanized anti-interleukin-6 receptor antibody: a multicenter, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500701615017

Interleukin 6 plays a key role in the development of antigen-induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500701615017

Genetic and environmental influences on IL-6 and TNF-alpha plasma levels in apparently healthy general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500701615017

Cytokine production of stimulated whole blood cultures in rheumatoid arthritis patients receiving short-term infliximab therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500701615017

Markers of inflammation are negatively correlated with serum leptin in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500701615017

Interleukin-6 trans-signalling in chronic inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500701615017

Pro-inflammatory cytokines in rheumatoid arthritis: pathogenetic and therapeutic aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500701615017

Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500701615017

Carbohydrate ingestion attenuates the increase in plasma interleukin-6, but not skeletal muscle interleukin-6 mRNA, during exercise in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500701615017

Anti–interleukin-6 receptor antibody therapy favors adrenal androgen secretion in patients with rheumatoid arthritis: A randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500701615017

Interleukin-6 (IL-6) in synovial fluid and serum of patients with rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500701615017

Interleukin (IL)-6 induction of osteoclast differentiation depends on IL-6 receptors expressed on osteoblastic cells but not on osteoclast progenitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500701615017

Adverse effects of modest sleep restriction on sleepiness, performance, and inflammatory cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500701615017

IL-6 and its circadian secretion in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500701615017

The role of the interleukin‐6 family of cytokines in inflammatory arthritis and bone turnover

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500701615017